267 related articles for article (PubMed ID: 17974485)
1. Decreased circulating iNKT cell numbers in refractory coeliac disease.
Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
[TBL] [Abstract][Full Text] [Related]
2. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
5. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
6. Refractory coeliac disease.
Daum S; Cellier C; Mulder CJ
Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
[TBL] [Abstract][Full Text] [Related]
7. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
8. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
Verbeek WH; von Blomberg BM; Scholten PE; Kuik DJ; Mulder CJ; Schreurs MW
Am J Gastroenterol; 2008 Dec; 103(12):3152-8. PubMed ID: 19086962
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in refractory coeliac disease: a review.
Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
[TBL] [Abstract][Full Text] [Related]
10. Cladribine therapy in refractory celiac disease with aberrant T cells.
Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
[TBL] [Abstract][Full Text] [Related]
11. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
[TBL] [Abstract][Full Text] [Related]
12. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
13. Phenotypical characterization of peripheral blood T cells in patients with coeliac disease: elevation of antigen-primed CD45RO+ T lymphocytes.
Kerttula TO; Hällström O; Mäki M
Immunology; 1995 Sep; 86(1):104-9. PubMed ID: 7590868
[TBL] [Abstract][Full Text] [Related]
14. CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity.
Mastrandrea F; Semeraro FP; Coradduzza G; Manelli M; Scarcia G; Pezzuto F; Serio G
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):90-103. PubMed ID: 19334373
[TBL] [Abstract][Full Text] [Related]
15. Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Assunta B; Plantone D; Cammarota G; Tonali PA; Batocchi AP
Hum Immunol; 2009 Jun; 70(6):430-5. PubMed ID: 19364517
[TBL] [Abstract][Full Text] [Related]
16. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
17. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.
Molling JW; Langius JA; Langendijk JA; Leemans CR; Bontkes HJ; van der Vliet HJ; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
J Clin Oncol; 2007 Mar; 25(7):862-8. PubMed ID: 17327607
[TBL] [Abstract][Full Text] [Related]
18. Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum.
Montalvillo E; Bernardo D; Martínez-Abad B; Allegretti Y; Fernández-Salazar L; Calvo C; Chirdo FG; Garrote JA; Arranz E
Nutrients; 2015 Oct; 7(11):8960-76. PubMed ID: 26529008
[TBL] [Abstract][Full Text] [Related]
19. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease.
Liu H; Brais R; Lavergne-Slove A; Jeng Q; Payne K; Ye H; Liu Z; Carreras J; Huang Y; Bacon CM; Hamoudi RA; Save V; Venkatraman L; Isaacson PG; Woodward J; Du MQ
Gut; 2010 Apr; 59(4):452-60. PubMed ID: 19996326
[TBL] [Abstract][Full Text] [Related]
20. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.
Peralbo E; DelaRosa O; Gayoso I; Pita ML; Tarazona R; Solana R
Biogerontology; 2006; 7(5-6):483-92. PubMed ID: 16953330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]